Work

Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? – Authors’ reply

Year: 2021

Type: letter

Source: The Lancet

DOI: 10.1016/s0140-6736(21)02317-5

Authors: Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, Madhavi Yadavalli, Magnus Nord

Institutions: AstraZeneca (United States), AstraZeneca (Sweden), AstraZeneca (United Kingdom)

Language: English

Topic: Heparin-Induced Thrombocytopenia and Thrombosis

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca, University of Washington, Massey University, University of Canberra, Oulun Yliopisto, School of Life and Environmental Sciences, Deakin University

OpenAlex ID: W3211989211

Cites: 4

Cited by:

Related to: 10